Page last updated: 2024-09-04

cyc 202 and 4,5,6,7-tetrabromo-2-azabenzimidazole

cyc 202 has been researched along with 4,5,6,7-tetrabromo-2-azabenzimidazole in 2 studies

Compound Research Comparison

Studies (cyc 202)	Trials (cyc 202)	Recent Studies (post-2010) (cyc 202)	Studies (4,5,6,7-tetrabromo-2-azabenzimidazole)	Trials (4,5,6,7-tetrabromo-2-azabenzimidazole)	Recent Studies (post-2010) (4,5,6,7-tetrabromo-2-azabenzimidazole)
979	7	393	115	0	57

Protein Interaction Comparison

Protein	Taxonomy	4,5,6,7-tetrabromo-2-azabenzimidazole (IC50)
Chain A, Cell division protein kinase 2	Homo sapiens (human)	15.6
Casein kinase II subunit alpha'	Homo sapiens (human)	0.7325
Casein kinase II subunit beta	Homo sapiens (human)	0.7325
Casein kinase II subunit alpha	Homo sapiens (human)	0.7354
Dual specificity tyrosine-phosphorylation-regulated kinase 1A	Homo sapiens (human)	2.68
Casein kinase II subunit alpha 3	Homo sapiens (human)	0.8667

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M	1
Jarhad, DB; Jeong, LS; Kim, HR; Mashelkar, KK; Noh, M	1

Reviews

1 review(s) available for cyc 202 and 4,5,6,7-tetrabromo-2-azabenzimidazole

Article	Year
Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics. Journal of medicinal chemistry, 2018, 11-21, Volume: 61, Issue:22 Topics: Animals; Biological Products; Disease; Dyrk Kinases; Enzyme Activation; Humans; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases	2018

Other Studies

1 other study(ies) available for cyc 202 and 4,5,6,7-tetrabromo-2-azabenzimidazole

Article	Year
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51 Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases	2007

Article

Year

A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.

Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007